ArticleFrontiers in oncology2025

Case Report: Two cases of chemotherapy refractory aggressive variant prostate cancer with extreme durable response to PARP inhibitor.

Bohao Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.